Advertisement

Topics

Seattle Prostate Institute Company Profile

05:48 EDT 18th June 2018 | BioPortfolio

The Seattle Prostate Institute was established in 1997 by a group of physicians who, in the mid-1980's, had pioneered the introduction and development of ultrasound-guided prostate implantation in the United States from their base at Seattle's Northwest Hospital. After relocating to Swedish Medical Center, another of the city's premier institutions, these physicians sought to expand and improve upon the work they had started with an emphasis on the highest standards of patient care, medical research, and clinical education. To date, SPI physicians have performed more that 4,000 prostate implants. Of the patients treated at SPI, half have come from other states and from other countries in order to benefit from the expertise that has been developed in Seattle.The Leadership Role and professional reputation of the SPI medical team has firmly established the Institute as the leading center of expertise in the area of prostate brachytherapy. Not only do patients come from around the nation and around the world for consultation and treatment, but physicians and other health professionals from the U.S. and abroad are also drawn to Seattle to participate in SPI's highly respected clinical education and training programs. To further demonstrate its commitment to high standards of clinical practice, the Institute has recently initiated a voluntary accreditation and quality assurance program through which it provides technical assistance and ongoing monitoring to medical centers establishing new prostate implant programs or reassessing existing ones. Overall, the research and professional activities of the Institute's physicians and staff have contributed greatly to the understanding and acceptance of prostate implantation by the medical community and by the public.

Location

1101 Madison| Suite 1101
Seattle
Washington
98104
United States of America

Contact

Phone: 206.215.2480
Fax: 206.215.2481


News Articles [1625 Associated News Articles listed on BioPortfolio]

Abiraterone not recommended by UK’s NICE as first-line treatment for advanced prostate cancer

The Institute of Cancer Research, London, has expressed disappointment that the prostate cancer drug abiraterone will not be made available to men with advanced prostate cancer as a first-line treatme...

Non-car commuting options winning over downtown Seattle workers in droves

So, what’s it like for a city’s downtown workers to forego the car and utilize other means in terms of satisfying or fulfilling duties? Just ask Seattle, Washington, the Pacific Northwest-...

Prostate Cancer Risk Prediction Improved by DNA Test Sensitive to New Gene Variants

New testing strategies for prostate cancer, including noninvasive saliva tests, may be close to hand, now that an in-depth study of DNA samples from more than 140,000 men has implicated 63 additional ...

Landmark study links tumor evolution to prostate cancer severity

(Ontario Institute for Cancer Research) Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of a...

Rutgers researcher receives $1 million grant for international prostate cancer study

A $1 million grant from Gateway for Cancer Research will help Rutgers Cancer Institute of New Jersey Urologic Oncology Chief Isaac Yi Kim, MD, PhD, MBA evaluate the impact of surgically removing the p...

Take with Food: Study Tests Lowering Dose of Prostate Cancer Drug

Source: National Cancer Institute - Related MedlinePlus Pages: Prostate Cancer

Molecular Switch Links High-Fat Diet to Prostate Cancer Metastasis

Source: National Cancer Institute - Related MedlinePlus Pages: Prostate Cancer

Keytruda offers significant hope in subset of prostate cancer

Up until present, no studies had shown that immunotherapies could offer potential treatment for men with prostate cancer; however, at ASCO, a team from The Institute of Cancer Research and The Royal M...

PubMed Articles [1399 Associated PubMed Articles listed on BioPortfolio]

Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.

Investigators have used administrative claims to better understand cancer outcomes when a research question cannot feasibly be examined within a study. The Prostate Cancer Prevention Trial (PCPT) show...

Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.

Although people living with HIV or AIDS (PLWHA) are at higher risk for many cancers, breast, prostate, and colorectal cancer rates are lower in this patient population. Because these tumors are often ...

Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches.

Prostate Cancer is the forth most common type of cancer. Prostate-specific membrane antigen (PSMA) is anchored in the cell membrane of prostate epithelial cells. PSMA is highly expressed on prostate e...

Influence of the neural microenvironment on prostate cancer.

Nerves are key factors in prostate cancer (PCa), but the functional role of innervation in prostate cancer is poorly understood. PCa induced neurogenesis and perineural invasion (PNI), are associated ...

Reduced Risk of Prostate Cancer With 5α-Reductase Inhibitors.

Clinical Trials [2868 Associated Clinical Trials listed on BioPortfolio]

Impact of Non-Commercialism Policy in Seattle Schools

This is a 3-year pilot study funded by National Institute of Health will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on and adopted b...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

Addressing Prostate Cancer Information Disparities With eHealth Technology

his is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that wil...

Impact of Non-Commercialism Policy in Seattle Schools

This pilot study on the impact of a non-commercialism policy in Seattle schools will assess and evaluate obesity-related health outcomes of a real-life policy decision, recently voted on a...

Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer

Background: Prostate cancer is one of the most common cancers for men in the U.S. There are some new ways to take pictures of the cancer. There are also new ways to use image-guided biops...

Companies [1530 Associated Companies listed on BioPortfolio]

Seattle Prostate Institute

The Seattle Prostate Institute was established in 1997 by a group of physicians who, in the mid-1980's, had pioneered the introduction and development of ultrasound-guided prostate implantation in the...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

The Prostate Cancer Foundation

The Prostate Cancer Foundation is the world’s largest philanthropic source of support for prostate cancer research focused on discovering better treatments and a cure for pro...

Prostate Cancer Education Council

Prostate cancer remains the second-leading cause of cancer death in American men. More than 220,000 men will be diagnosed with prostate cancer this year and it is expected that 27,000 men will die fro...

Talaris Institute

Talaris Institute is a Seattle-based nonprofit whose mission is to support parents and caregivers in raising socially and emotionally healthy children. To learn more about Talaris Institute, please vi...

More Information about "Seattle Prostate Institute" on BioPortfolio

We have published hundreds of Seattle Prostate Institute news stories on BioPortfolio along with dozens of Seattle Prostate Institute Clinical Trials and PubMed Articles about Seattle Prostate Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Seattle Prostate Institute Companies in our database. You can also find out about relevant Seattle Prostate Institute Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Radiology
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...


Corporate Database Quicklinks



Searches Linking to this Company Record